Servier Pharmaceuticals, shared on LinkedIn:
“At Servier, we know that a blood cancer diagnosis extends beyond the individual living with it. It touches families, caregivers, friendships, futures, and the moments that matter most.
This Blood Cancer Awareness Month, we recognize the strength and resilience of the blood cancer community.
For people affected by acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and other blood cancers, the need for innovation has never been more important.
Through research and scientific collaboration, we are committed to advancing new possibilities for patients and helping build a future where more people can look ahead with greater confidence and hope.
Learn more about our commitment to the blood cancer community.”